The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetra Diamonds Regulatory News (PDL)

Share Price Information for Petra Diamonds (PDL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.80
Bid: 44.50
Ask: 45.00
Change: 3.60 (8.74%)
Spread: 0.50 (1.124%)
Open: 42.00
High: 45.00
Low: 42.00
Prev. Close: 41.20
PDL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Transactions of Directors

27 Oct 2016 12:00

RNS Number : 6247N
Petra Diamonds Limited
27 October 2016
 

 

 

27 October 2016 LSE: PDL

Petra Diamonds Limited

("Petra," "the Company" or "the Group")

Notification of Transactions of Directors

Petra Diamonds Limited announces the following transactions of Directors:

This notification is made in accordance with Disclosure Rule 3.1 of the Disclosure Guidance and Transparency Rules ("DTR") and Article 19(3) of the Market Abuse Regulation ("MAR").

1. Director transactions

On 27 October 2016, Johan Dippenaar and Jim Davidson became beneficiaries of a trust, African Rainbow Trust of which, inter alia, Adonis Pouroulis is currently a beneficiary (the "Transaction"). As previously announced by the Company on 14 April 2009 and 10 December 2009, ordinary shares in the share capital of the Company ("Shares") were acquired and registered in the trust ("Trust Shares"). Prior to completion of the Transaction, neither Johan Dippenaar nor Jim Davidson had any interest, voting or dividend rights in the Trust Shares.

The announcements referenced above can be accessed by opening the below links:

https://irssl.euroinvestor.com/asp/ir/PetraDiamonds/https/NewsRead.aspx?storyid=13082494&ishtml=0

https://irssl.euroinvestor.com/asp/ir/PetraDiamonds/https/NewsRead.aspx?storyid=13082478&ishtml=0 

Following completion of the Transaction, the interest in the Trust Shares are equally divided amongst the beneficiaries of the trust. The transaction will provide Johan Dippenaar and Jim Davidson with an interest in 1,052,637 Shares each, while Adonis Pouroulis' interest will reduce by 777,013 Shares and the remaining beneficiaries' interest will reduce by 1,328,261 Shares. Johan Dippenaar and Jim Davidson are not required to pay any further consideration in connection with the Transaction.

Further, on 27 October 2016, Johan Dippenaar acquired 2,796,616 Shares and Jim Davidson acquired 2,716,569 Shares respectively (in aggregate, the "Crown Shares"). These shares were acquired from the previous controlling shareholders of Crown Diamonds NL ("Crown") (the company which Petra merged with in 2005) and the private company structure that preceded Crown. The shares were acquired for nil consideration pursuant to a non-contractual agreement between the parties. Prior to this transfer, neither Johan Dippenaar nor Jim Davidson had any interest, voting or dividend rights in the Crown Shares.

There are currently 529,989,968 Ordinary Shares in issue, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in (or a change to their interest in) Petra under the FCA's Disclosure and Transparency Rules.

2. Changes to Directors' shareholdings

As a result of the transactions described above, the following directors' interests in the Company as at 27 October 2016, are as follows:

Director

Total Holding of Ordinary Shares prior to completion of the transactions

Shareholding post completion of the Transactions

Resulting Percentage Holding in the Company

Adonis Pouroulis

9,564,650

8,787,637

1.66%

Johan Dippenaar

1,160,719

5,009,972

0.95%

Jim Davidson

1,043,775

4,812,981

0.91%

 

 

 

 

 

§ Ends §

For further information, please contact:

 

Petra Diamonds, London

Telephone: +44 20 7494 8203

Salisha Ilyas

salisha.ilyas@petradiamonds.com

 

 

Buchanan

Telephone: 44 20 7466 5000

(PR Adviser)

 

Bobby Morse

bobbym@buchanan.uk.com

Anna Michniewicz

annam@buchanan.uk.com

 

 

RBC Capital Markets

Telephone: +44 20 7653 4000

(Joint Broker)

 

Matthew Coakes

matthew.coakes@rbccm.com

Jonathan Hardy

jonathan.hardy@rbccm.com

 

 

Barclays

Telephone: +44 20 7623 2323

(Joint Broker)

 

Bertie Whitehead

bertie.whitehead@barclays.com

Philip Drake

philip.e.drake@barclays.com

 

 

BMO Capital Markets

Telephone: +44 20 7236 1010

(Joint Broker)

 

Jeffery Couch

jeffery.couch@bmo.com

Neil Haycock

neil.haycock@bmo.com

 

 

Follow our corporate news feed on Twitter Follow our dedicated investor relations news feed on Twitter Follow us on LinkedIn  

 

About Petra Diamonds Limited

Petra Diamonds is a leading independent diamond mining group and an increasingly important supplier of rough diamonds to the international market. The Company has interests in five producing operations: three underground mines in South Africa (Finsch, Cullinan and Koffiefontein), the Kimberley Operations (including the Kimberley Underground mine and extensive tailings retreatment operations) and one open pit mine in Tanzania (Williamson). It also maintains an exploration programme in Botswana.

 

Petra has a core objective to steadily increase annual production to ca. 5.3 million carats by FY 2019. The Group has a significant resource base in excess of 300 million carats.

 

Petra conducts all operations according to the highest ethical standards and will only operate in countries which are members of the Kimberley Process. Petra is quoted with a premium listing on the Main Market of the London Stock Exchange under the ticker 'PDL' and is a constituent of the FTSE4Good Index. For more information, visit the Company's website at www.petradiamonds.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHVDLBLQBFEFBQ
Date   Source Headline
16th Apr 20247:00 amPRNQ3 FY 2024 Operating Update and Final Sales Results for Tender 5 FY 2024
9th Apr 20247:00 amPRNNotification of Q3 FY 2024 Operating Update
8th Apr 20247:00 amPRNCost savings target increased to more than US$30m per annum and entry into definitive transaction agreement for the sale of Koffiefontein.
8th Mar 20247:23 amPRNDirectorate Change
20th Feb 20247:00 amRNSH1 FY 2024 Interim Results
16th Feb 20247:00 amRNSFinal sales results for Tender 4 FY 2024
13th Feb 20247:00 amRNSNotification of H1 FY 2024 Interim Results
18th Jan 20247:00 amRNSDirector Share Awards
16th Jan 20247:00 amRNSH1 FY 2024 Operating Update
10th Jan 20247:00 amRNSNotification of H1 FY 2024 Operating Update
21st Dec 202310:40 amRNSDirectorate Change
20th Dec 20237:00 amRNSBoard Changes
14th Dec 20237:00 amRNSFinal sales results for Tender 3 FY 2024
13th Dec 202310:47 amRNSPotential Sale of Koffiefontein
8th Dec 20231:00 pmRNSHolding(s) in Company
8th Dec 202311:23 amRNSListing Rule 9.6.14 (R) Disclosure
8th Dec 20237:00 amRNSInitial sales results for Tender 3 FY 2024
8th Dec 20237:00 amRNSApproval of increase in Revolving Credit Facility
6th Dec 202312:25 pmRNSHolding(s) in Company
14th Nov 202311:06 amRNSResult of AGM
13th Nov 20232:45 pmRNSDirectorate Change
8th Nov 20234:03 pmRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSImproved resilience through capital deferrals
24th Oct 20233:21 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSQ1 FY 2024 Operating Update
19th Oct 20237:00 amRNSDirector Share Awards
19th Oct 20237:00 amRNSDirector Share Vesting
17th Oct 20237:01 amRNSNotification of Q1 FY 2024 Operating Update
17th Oct 20237:00 amRNSSales results for Tender 2 FY 2024
11th Oct 202310:54 amRNSHolding(s) in Company
10th Oct 20237:00 amRNSPublication of 2023 Reports and Notice of AGM
6th Oct 20237:00 amRNSInitial sales results for 75% of Tender 2 FY 2024
15th Sep 20237:01 amRNSDirectorate Change
15th Sep 20237:00 amRNSPreliminary Results for FY 2023
11th Sep 202311:10 amRNSShort delay of FY 2023 Preliminary Results
5th Sep 20237:00 amRNSNotification of FY 2023 Preliminary Results
25th Aug 20237:00 amRNSFirst tender of FY 2024 yields US$79.3m in sales
10th Aug 20232:15 pmRNSHolding(s) in Company
9th Aug 202310:04 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSQ4 and FY 2023 Operating Update
12th Jul 20237:00 amRNSNotification of Q4 and FY 2023 Operating Update
28th Jun 20237:00 amRNSPublication of Presentation
7th Jun 20237:00 amRNSPostponement of Tender 6 FY 2023
31st May 20237:00 amRNSClass 2 Announcement
19th May 20234:00 pmRNSHolding(s) in Company
19th May 20237:00 amRNSSales results for Tender 5 FY 2023
9th May 20238:55 amRNSDirector Declaration
25th Apr 202310:00 amRNSHolding(s) in Company
24th Apr 202310:00 amRNSHolding(s) in Company
21st Apr 202310:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.